| 4B6L: Discovery Of Oral Polo-Like Kinase (Plk) Inhibitors With Enh Selectivity Profile Using Residue Targeted Drug Design |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).
| 4B6L: Discovery Of Oral Polo-Like Kinase (Plk) Inhibitors With Enh Selectivity Profile Using Residue Targeted Drug Design |
This OCA
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).